X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3393) 3393
Newsletter (184) 184
Publication (173) 173
Book Review (27) 27
Book Chapter (13) 13
Conference Proceeding (8) 8
Newspaper Article (7) 7
Magazine Article (2) 2
Book / eBook (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1815) 1815
galactose (1694) 1694
index medicus (1372) 1372
humans (1170) 1170
male (1140) 1140
rats (856) 856
mice (815) 815
female (754) 754
galactose - metabolism (572) 572
d-galactose (491) 491
galactose - administration & dosage (437) 437
biochemistry & molecular biology (419) 419
oxidative stress (419) 419
analysis (409) 409
glucose (402) 402
pharmacology & pharmacy (354) 354
galactose - pharmacology (335) 335
research (332) 332
adult (292) 292
polysaccharides (279) 279
liver - metabolism (276) 276
aging (240) 240
antioxidants (239) 239
liver (239) 239
galactose - chemistry (231) 231
metabolism (223) 223
proteins (220) 220
rats, sprague-dawley (219) 219
brain (212) 212
middle aged (212) 212
physiological aspects (206) 206
dextrose (205) 205
enzymes (202) 202
apoptosis (198) 198
glucose - metabolism (197) 197
disease models, animal (196) 196
time factors (185) 185
rodents (183) 183
cells (182) 182
research article (176) 176
medicine, research & experimental (175) 175
expression (174) 174
neurosciences (174) 174
chemistry, applied (173) 173
health aspects (170) 170
diet (163) 163
food science & technology (163) 163
carbohydrates (160) 160
biotechnology & applied microbiology (155) 155
in-vitro (154) 154
cell biology (152) 152
oxidative stress - drug effects (151) 151
rats, wistar (149) 149
medicine (147) 147
endocrinology & metabolism (143) 143
gene expression (138) 138
polymer science (138) 138
nutrition & dietetics (135) 135
glycosylation (133) 133
dose-response relationship, drug (131) 131
rats, inbred strains (131) 131
alzheimers-disease (129) 129
lactose (129) 129
administration, oral (126) 126
fructose (125) 125
chemistry (124) 124
in-vivo (124) 124
multidisciplinary sciences (122) 122
cancer (121) 121
galactose - toxicity (119) 119
liver - drug effects (118) 118
memory (118) 118
kinetics (116) 116
sugars (116) 116
aged (113) 113
inflammation (113) 113
immunology (112) 112
monosaccharides (110) 110
antioxidants - pharmacology (108) 108
alzheimer's disease (106) 106
aldehyde reductase - antagonists & inhibitors (105) 105
physiology (105) 105
purification (105) 105
superoxide (105) 105
chemistry, organic (104) 104
ophthalmology (103) 103
studies (103) 103
article (102) 102
mice, inbred c57bl (102) 102
biochemistry (101) 101
cell line, tumor (101) 101
cells, cultured (101) 101
diabetes (101) 101
lectins (100) 100
microbiology (100) 100
science (100) 100
aging - drug effects (99) 99
brain - metabolism (98) 98
life sciences (98) 98
chemistry, multidisciplinary (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3458) 3458
German (44) 44
Chinese (26) 26
Japanese (18) 18
French (11) 11
Russian (11) 11
Italian (8) 8
Spanish (7) 7
Hungarian (4) 4
Czech (3) 3
Ukrainian (3) 3
Danish (1) 1
Dutch (1) 1
Korean (1) 1
Polish (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Fundamental & Clinical Pharmacology, ISSN 0767-3981, 08/2018, Volume 32, Issue 4, pp. 392 - 399
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 10/2013, Volume 305, Issue 7, pp. R840 - R853
Post-oral sugar actions enhance the intake of and preference for sugar-rich foods, a process referred to as appetition. Here, we investigated the role of... 
Post-oral sugar conditioning | Glucose | Galactose | Fructose | glucose | PHYSIOLOGY | TASTE-AVERSION | RAT INTESTINE | C57BL/6J MICE | TRANSPORTERS | fructose | PEPTIDE-1 GLP-1 | galactose | NUTRIENT-DRIVEN SATIETY | FOOD PREFERENCES | post-oral sugar conditioning | SODIUM-GLUCOSE COTRANSPORTER | RECEPTORS | CONDITIONED FLAVOR PREFERENCES | Glucose Transporter Type 2 - drug effects | Intestines - drug effects | Galactose - metabolism | Male | Intestines - metabolism | Fructose - metabolism | Glucose Transporter Type 2 - metabolism | Intestinal Absorption | Glucose - administration & dosage | Self Administration | Methylglucosides - administration & dosage | Time Factors | Sodium-Glucose Transport Proteins - metabolism | Saccharin - administration & dosage | Sodium-Glucose Transporter 1 - metabolism | Administration, Oral | Conditioning (Psychology) - drug effects | Food Preferences - drug effects | Mice, Inbred C57BL | Appetite Regulation - drug effects | Sodium-Glucose Transporter 1 - drug effects | Sodium-Glucose Transport Proteins - drug effects | Animals | Glucose - metabolism | Ligands | Drinking - drug effects | Mice | Methylglucosides - metabolism | Galactose - administration & dosage | Sweetening Agents - administration & dosage | Fructose - administration & dosage | Carbohydrates - administration & dosage | Carbohydrate metabolism | Research | Obesity, Diabetes and Energy Homeostasis
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0166830
Galactose-deficient IgA1 (Gd-IgA1) and IgA-IgG complexes are known to play an important role in the pathogenesis of IgA nephropathy (IgAN). We aimed therefore... 
IMMUNE-COMPLEXES | AUTOANTIBODIES | ANTIBODIES | CYTOKINES | HUMAN MESANGIAL CELLS | MULTIDISCIPLINARY SCIENCES | PROLIFERATION | KAPPA-B | GLYCOSYLATION | PROGRESSION | SEVERITY | Immunoglobulin G - blood | Kidney - pathology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Male | Glomerulonephritis, IGA - drug therapy | Galactose - blood | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Glomerulonephritis, IGA - pathology | Immunosuppressive Agents - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Sirolimus - therapeutic use | Sirolimus - administration & dosage | Tacrolimus - therapeutic use | Mycophenolic Acid - therapeutic use | Antibodies, Monoclonal - administration & dosage | Galactose - deficiency | Immunoglobulin A - blood | Glomerulonephritis, IGA - blood | Prednisone - therapeutic use | IgA glomerulonephritis | Care and treatment | Immunosuppression | Analysis | Dosage and administration | Research | Galactose | Immunosuppressive agents | Drugs | Nephrology | Transplants & implants | Cytokines | Syngeneic grafts | Pathogenesis | Immunoglobulin G | Gadolinium | Transplantation | Inflammation | Exposure | Prednisone | Regression analysis | Immunoglobulin A | Epidemiology | Patients | Serum levels | IgA nephropathy | Tacrolimus | Biopsy | Kidney transplantation
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 02/2011, Volume 22, Issue 2, pp. 136 - 147
Galactosyl-terminated drug carriers are known to enhance drug accumulation in the liver, while possible accompanying hepatic toxicity is usually not clarified.... 
α,β-poly[(2-hydroxyethyl)-L-aspartamide] | doxorubicin | galactosyl | hepatotoxicity | hepatocellular carcinoma | POLYMER-BOUND DOXORUBICIN | PERFORMANCE | CARDIOTOXICITY | SYSTEMIC THERAPY | LACTOSAMINATED HUMAN ALBUMIN | alpha, beta-poly[(2-hydroxyethyl)-L-aspartamide] | PHARMACOKINETICS | ONCOLOGY | N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMERS | ADRIAMYCIN | CONJUGATE | PHARMACOLOGY & PHARMACY | PHASE-I | Antibiotics, Antineoplastic - toxicity | Humans | Peptides - pharmacokinetics | Drug Carriers - administration & dosage | Drug Carriers - toxicity | Peptides - administration & dosage | Galactose - analogs & derivatives | Liver Neoplasms, Experimental - metabolism | Peptides - toxicity | Doxorubicin - analogs & derivatives | Female | Antibiotics, Antineoplastic - pharmacokinetics | Heart Diseases - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxorubicin - administration & dosage | Galactose - pharmacokinetics | Doxorubicin - pharmacokinetics | Doxorubicin - toxicity | Mice, Inbred ICR | Antibiotics, Antineoplastic - administration & dosage | Animals | Liver Neoplasms, Experimental - drug therapy | Cell Line, Tumor | Galactose - toxicity | Drug Carriers - pharmacokinetics | Mice | HeLa Cells | Galactose - administration & dosage | Toxicity Tests | Drug Screening Assays, Antitumor | Index Medicus
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 08/2012, Volume 432, Issue 1-2, pp. 99 - 104
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 04/2016, Volume 302, pp. 35 - 43
-Galactose ( -gal) is a reducing sugar that can be used to mimic the characteristics of aging in rodents; however, the effects of -gal administration by oral... 
Aging | Oral d-galactose | Oxidative damage | Cognitive impairment | Oral D-galactose | NERVOUS-SYSTEM | ALZHEIMERS-DISEASE | NEURODEGENERATION | MODEL | NEUROSCIENCES | MITOCHONDRIAL DYSFUNCTION | BEHAVIORAL SCIENCES | MICE | STRESS | DEFICITS | BRAIN | AGING RATS | Galactose | Neurosciences
Journal Article
Neurobiology of Learning and Memory, ISSN 1074-7427, 2010, Volume 93, Issue 2, pp. 157 - 164
Previous evidence showed that administration of -galactose ( -gal) increased ROS production and resulted in impairment of cholinergic system. Troxerutin, a... 
AchE | Cholinergic system | d-Galactose | nAchRα7 | ROS | Troxerutin | OXIDATIVE STRESS | ACETYLCHOLINE | ALZHEIMERS-DISEASE | BETA-AMYLOID PEPTIDE | RECEPTOR | ALPHA-LIPOIC ACID | nAchR alpha 7 | NEUROTOXICITY | NEUROSCIENCES | PSYCHOLOGY | PSYCHOLOGY, MULTIDISCIPLINARY | ADVANCED GLYCATION | MEMORY | BEHAVIORAL SCIENCES | MICE | D-Galactose | Disks Large Homolog 4 Protein | Galactose - metabolism | Reactive Oxygen Species - metabolism | Frontal Lobe - metabolism | Receptors, N-Methyl-D-Aspartate - metabolism | Brain - enzymology | Male | Intracellular Signaling Peptides and Proteins - metabolism | Hippocampus - drug effects | Protein Carbonylation - drug effects | Prosencephalon - enzymology | Prosencephalon - drug effects | Brain - metabolism | Neuroprotective Agents - pharmacology | Hippocampus - enzymology | Membrane Proteins - metabolism | Prosencephalon - metabolism | Neuroprotective Agents - administration & dosage | Hydroxyethylrutoside - analogs & derivatives | Receptors, Nicotinic - metabolism | Hydroxyethylrutoside - pharmacology | Random Allocation | Frontal Lobe - enzymology | Maze Learning - drug effects | Brain - drug effects | Neuropsychological Tests | Hippocampus - metabolism | Animals | Guanylate Kinases | Frontal Lobe - drug effects | Glycation End Products, Advanced - metabolism | Galactose - toxicity | Hydroxyethylrutoside - administration & dosage | Avoidance Learning - drug effects | Mice | Acetylcholinesterase - metabolism | alpha7 Nicotinic Acetylcholine Receptor | Methyl aspartate | Flavonoids | Medicine, Herbal | Flavones | Bioflavonoids | Medicine, Botanic | Brain | Enzymes | Neurology | Cognition & reasoning | Rodents | Acetylcholine receptors (nicotinic)
Journal Article
Journal Article